+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Compounded analgesic therapy for disorders of movement: arthritis, neuropathic pain, and postpolio syndrome

Compounded analgesic therapy for disorders of movement: arthritis, neuropathic pain, and postpolio syndrome

International Journal of Pharmaceutical Compounding 14(3): 182-192

Pain caused by disorders of movement is often chronic and severe and may not be alleviated by commercially available medications. In such cases, the use of a compounded formulation can provide relief, either as sole therapy or as part of a combination treatment regimen. In this report, we review the effects of compounded analgesic preparations on chronic severe pain like that produced by arthritis, neuropathy, or postpolio syndrome. Case reports are included, formulations are presented, and two patients (one of whom, RFM III, is a coauthor of this paper) with a painful movement disorder describe their response to custom compounded therapy.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 052269278

Download citation: RISBibTeXText

PMID: 23965495

Related references

Chronic narcotic analgesic therapy for neuropathic pain syndromes. Neurology 42(4 SUPPL 3): 391, 1992

Use of cortical stimulation in neuropathic pain, tinnitus, depression, and movement disorders. Neurotherapeutics 11(3): 564-571, 2015

Percutaneous electrical nerve stimulation: a novel analgesic therapy for diabetic neuropathic pain. Diabetes Care 23(3): 365-370, 2000

Specific features of analgesic effect of docosahexaenoic acid in rats with neuropathic pain syndrome. Bulletin of Experimental Biology and Medicine 156(5): 699-701, 2014

Topical treatment of neuropathic pain using compounded medications. Clinical Journal of Pain 30(1): 73-91, 2014

Analgesic issues in palliative care, furthering our understanding of pain, the stability and cost of opioid infusion therapy, and opioid effectiveness doses in nociceptive and neuropathic pain. Journal of Pain & Palliative Care PharmacoTherapy 16(3): 77-81, 2003

Alpha-1 adrenoceptor hyperresponsiveness in three neuropathic pain states: complex regional pain syndrome 1, diabetic peripheral neuropathic pain and central pain states following spinal cord injury. Pain Research & Management 9(2): 89-97, 2004

Analgesic effects of ketamine infusion therapy in korean patients with neuropathic pain: A 2-week, open-label, uncontrolled study. Current Therapeutic Research, Clinical and Experimental 71(2): 93-104, 2010

5% Lidocaine-medicated plaster for the treatment of chronic peripheral neuropathic pain: complex regional pain syndrome and other neuropathic conditions. Journal of Pain Research 9(): 763-770, 2016

Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic pain. Journal of Neuroscience 29(44): 14015-14025, 2009

Analgesic efficacy of chronic intrathecal saline in experimental neuropathic pain Implications for human intrathecal drug therapy. Journal of Neurosurgery 82(2): 372A, 1995

Retrospective Evaluation on the Analgesic Activities of 2 Compounded Topical Creams and Voltaren Gel in Chronic Noncancer Pain. American Journal of Therapeutics 22(5): 342-349, 2016

Pregabalin--a neuromodulator for the treatment of neuropathic pain, generalized anxiety disorders and fibromyalgia syndrome. Medizinische Monatsschrift für Pharmazeuten 30(11): 396-400, 2007

A registry of the aetiology and costs of neuropathic pain in pain clinics : results of the registry of aetiologies and costs (REC) in neuropathic pain disorders study. Clinical Drug Investigation 27(11): 771-782, 2007

Managing postpolio syndrome pain. Nursing 36(12 Pt.1): 17-17, 2006